Levitt asks Templeton to reconsider vote

Levitt asks Templeton to reconsider vote

Jerusalem: Taro Pharmaceuticals Industries Ltd’s chairman Barrie Levitt asked shareholder Templeton Asset Management Ltd in a letter on Sunday to reconsider a planned vote against the board at the annual meeting scheduled for 31 December.

Levitt’s letter was emailed to Bloomberg News.

Close